NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) (“Bio-Reference” or “the Company”) in connection with the sale of the Company to Opko Health, Inc. (NYSE: OPK).
Click here to learn about the case: http://docs.wongesq.com/BRLI-Info-Request-Form-748. There is no cost or obligation to you.
Under the terms of the transaction, Bio-Reference shareholders will receive 2.75 shares of Opko common stock for each share of Bio-Reference stock they own. The investigation concerns whether the Board of Bio-Reference breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Opko is underpaying for Bio-Reference shares.
If you own common stock in Bio-Reference and wish to obtain additional information, please contact Vincent Wong, Esq. either via email email@example.com, by telephone at 212.425.1140, or visit http://docs.wongesq.com/BRLI-Info-Request-Form-748.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.